七、八元瓜环对萘二胺异构体相互作用的考察

利用紫外吸收光谱、荧光光谱以及¹H NMR方法考察了七、八元瓜环(Q[7], Q[8])与1,8-萘二胺(g1), 2,3-萘二胺(g2), 1,5-萘二胺(g3)的相互作用. 实验结果表明: Q[7]与客体g1发生端口作用, 作用比为1∶1; Q[7]与客体g2, g3相互作用也形成1∶1的包结配合物. Q[8]与三种客体相互作用情况各不相同, 除Q[8]与客体g2相互作用形成1∶2的包结配合物; Q[8]与客体g1或g3可发生相互作用, 形成溶解性较差的作用产物, 其表观相互作用的比例为1∶1. 考察溶液酸度对主客体相互作用的影响还表明: 当pH大于某一值之后, 如Q[7]主客体体系, pH大于6.0; Q[8]主客体体系, pH大于12.0, 用光谱方法观察不到瓜环与客体的相互作用. Q[7], Q[8]为主体的上述主客体作用产物分别与金刚烷胺盐酸盐、1,10-癸二胺盐酸盐的竞争反应结果表明, 已作用的萘二胺异构体容易被所选用的竞争客体所取代, 只有g2与Q[8]形成的包结配合物被1,10-癸二胺盐酸盐部分取代.     

吡啶基咪唑[4,5-f]1,10-菲咯啉的合成、表征及与瓜环作用的光谱学考察

设计合成了2个吡啶基菲略啉衍生物2-(3-吡啶基)咪唑[4,5-f]1,10.菲咯啉(G1)和2-(4-吡啶基)咪唑[4,5-f]1,10-菲咯啉(G2),通过元素分析、质谱和核磁共振氢谱对其结构进行了表征.利用紫外吸收光谱和荧光光谱法考察了所合成化合物与六元瓜环Q[6]、七元瓜环Q[7]的相互作用,以及体系pH值对主-客体相互作用的影响.在酸性条件下,Q[6]、Q[7]与Gl以及Q[6]与G2均发生包合形成1∶1的包合物,并有荧光增敏作用;Q[7]与G2作用形成1∶2包合物,且对G2有荧光猝灭作用;Q[6]、Q[7]与G1的包合常数分别为3.00×104和1.86×104L/mol;Q[6]、Q[7]与G2的包合常数分别为1.64×104和1.01×103L/mol.随着体系酸性减弱,瓜环与客体作用减弱,在中性条件下,瓜环未与客体发生包合作用.     

吡啶基咪唑[4,5-f]1,10-菲咯啉合成、表征及与瓜环作用的光谱学考察

设计合成了2个吡啶基菲咯啉衍生物2-(3-吡啶基)咪唑[4,5-f]1,10-菲咯啉(G1)和2-(4-吡啶基)咪唑[4,5-f]1,10-菲咯啉(G2),通过元素分析、质谱和核磁共振氢谱对其结构进行了表征。 利用紫外吸收光谱和荧光光谱法考察了所合成化合物与六元瓜环Q[6]、七元瓜环Q[7]的相互作用,以及体系pH值对主-客体相互作用的影响。 在酸性条件下,Q[6]、Q[7]与Gl以及Q[6]与G2均发生包合形成1∶1的包合物,并有荧光增敏作用;Q[7]与G2作用形成1∶2包合物,且对G2有荧光猝灭作用;Q[6]、Q[7]与G1的包合常数分别为3.00×104和1.86×104 L/mol;Q[6]、Q[7]与G2的包合常数分别为1.64×104和1.01×103 L/mol。 随着体系酸性减弱,瓜环与客体作用减弱,在中性条件下,瓜环未与客体发生包合作用。     

阿德福韦双L-氨基酸酯与葫芦脲的主客体化学与抗乙型肝炎病毒活性研究

用1HNMR、荧光光谱和红外光谱方法研究阿德福韦双L-苯丙氨酸丙酯(FH-1)与改性六元葫芦脲(TMeQ[6])、七元葫芦脲(Q[7])以及八元葫芦脲(Q[8])的相互作用,探讨主客体作用位点及其识别机制.1HNMR图谱表明FH-1中苯丙氨酸残基部分进入葫芦脲的空腔内部受到屏蔽作用,而FH-1其它部分则位于葫芦脲端口外侧.荧光图谱表明FH-1与TMeQ[6],Q[7]与Q[8]分别形成1∶1或2∶1,1∶1或3∶1与2∶1的主客体包结配合物.红外光谱表明Q[7]与FH-1固体包合物发生了主客体相互作用,FH-1特征峰消失.吸湿性考察发现FH-1与Q[7]形成的固体包合物的吸湿稳定性明显提高,室温放置90d后仍然为白色固体.抗乙型肝炎病毒研究提示葫芦脲具有明显降低化合物细胞毒性,增加其抗病毒活性与作用选择性的效果.     

八元瓜环与常山碱的相互作用模式

利用紫外吸收光谱、 荧光光谱、 核磁共振氢谱及红外光谱等方法考察了八元瓜环(Q[8])对常山碱(Feb)的包结作用; 采用紫外吸收光谱法研究了Q[8]对Feb理化性质的影响及不同pH条件下Q[8]/Feb包合物溶液中Feb的释放及Q[8]/Feb包合物在人工肠液和人工胃液中的释放. 结果表明, 在pH=1.2的盐酸介质中, Q[8]与Feb可形成摩尔比1∶1的稳定主客体包合物, 结合常数为4.20×10 ⁴ L/mol. 在pH=1.2(人工胃液的pH值)时, Feb可与Q[8]形成稳定包合物; 在pH=6.8(人工肠液的pH值)时, Q[8]/Feb包合物可释放出单纯的游离Feb. 因此, Q[8]可作为Feb的一种潜在药物载体为减轻Feb呕吐副反应提供借鉴.     

Interaction of Cucurbit [ n = 7,8 ] uril with Ranitidine Hydrochloride and Slow Release Properties

研究了七元瓜环(Q[7])和八元瓜环(Q[8])与盐酸雷尼替丁(RH)的包合作用及包合物的体外药物缓释性能.采用紫外-可见光谱法测定了体系的包合比、包合稳定常数和药物累积释放度;用1H NMR技术考察了体系主-客体的包合作用.结果表明,Q[7]和Q[8]与RH在酸性及中性条件下均能发生1∶1包合作用,包合稳定常数分别为1.21 ×104和2.06X104 L/mol;在碱性条件下则不发生包合作用.原药RH,Q[7]-RH及Q[8]-RH包合物在人工胃液(pH=1.2)中的60 min累积释放度分别为89.1％,56.6％和38.4％;而在人工肠液(pH=6.8)中三者的60 min累积释放度分别为90.2％,58.7％和38.0％.实验结果表明,Q[7]及Q[8]包合对RH有明显的体外缓释作用.     

七、八元瓜环对盐酸雷尼替丁的包合作用及缓释性能

研究了七元瓜环(Q[7])和八元瓜环(Q[8])与盐酸雷尼替丁(RH)的包合作用及包合物的体外药物缓释性能.采用紫外-可见光谱法测定了体系的包合比、包合稳定常数和药物累积释放度;用1H NMR技术考察了体系主-客体的包合作用.结果表明,Q[7]和Q[8]与RH在酸性及中性条件下均能发生1∶1包合作用,包合稳定常数分别为1.21×104和2.06×104 L/mol;在碱性条件下则不发生包合作用.原药RH,Q[7]-RH及Q[8]-RH包合物在人工胃液(pH=1.2)中的60 min累积释放度分别为89.1%,56.6%和38.4%;而在人工肠液(pH=6.8)中三者的60 min累积释放度分别为90.2%,58.7%和38.0%.实验结果表明,Q[7]及Q[8]包合对RH有明显的体外缓释作用.     

七、八元瓜环对盐酸他克林的包合作用及pH敏感释药性能的研究

利用紫外光谱、荧光光谱、1H NMR等技术研究七元瓜环(Q[7])、八元瓜环(Q[8])与盐酸他克林(THA)的主-客体包合作用及pH敏感释药性能。测得Q[7]-THA、Q[8]-THA体系作用的包合比分别为2∶1和1∶1、包合平衡常数分别为1. 85×10~4L·mol~(-1)和1. 98×10~4L·mol~(-1)。在pH=1. 2、pH=4. 0、pH=6. 8介质中,包合物Q[7]-THA的400min体外累积释放分别为49. 58%、53. 80%、56. 48%,包合物Q[8]-THA的体外累积释放分别为46. 11%、47. 40%、51. 49%,THA原药的体外累积释放分别为99. 33%、98. 41%、96. 87%。结果表明Q[7]及Q[8]的包合对THA有明显的pH敏感性缓释作用。     

八元瓜环与黄岑苷的主客体相互作用及对黄岑苷性质的影响

利用紫外吸收光谱和核磁共振波谱(NMR)等方法考察了八元瓜环(Q[8])与黄岑苷(BAL)之间的相互作用.结果表明,Q[8]与BAL形成了摩尔比为1∶1的包结配合物,包结稳定常数K=2. 8×104L/mol.相溶解度法研究结果表明,当Q[8]浓度为100μmol/L时,可使BAL在水中的溶解度增加4. 5倍.采用2,2-联氮基-双-(3-乙基苯并噻唑-6-磺酸)二铵盐(ABTS)方法考察了Q[8]对BAL抗氧化活性的影响,BAL-Q[8]包合物与游离BAL均对ABTS自由基具有清除能力,IC50值分别为5. 48和5. 07μmol/L.在人工肠液中BAL和BAL-Q[8]包合物较稳定;而在人工胃液中BAL在6 h后迅速降解,BAL-Q[8]包合物则基本未降解,Q[8]显著提高了BAL在人工胃液中的稳定性.体外累积释放度研究结果表明,在人工胃液中Q[8]的介入提高了BAL的累积释放量,其数值提高了2倍;在人工肠液中BAL-Q[8]包合物的累积释放速度明显慢于BAL的累计释放速度,说明Q[8]包合BAL后对BAL有一定的缓释作用.     

七元瓜环与芦竹碱的主客体相互作用

利用紫外可见吸收光谱法和荧光光谱法分别考察了七元瓜环(Q[7])与芦竹碱(Gramine)在溶液中的主客体相互作用;考察了p H值对主客体相互作用的影响,并利用摩尔比法和Job法计算了主客体相互作用的作用比以及稳定常数;利用等温量热滴定法进一步考察了Q[7]与Gramine主客体相互作用的热力学参数。实验结果表明Gramine与Q[7]在很宽的p H介质条件下(2p H10)都能发生主客体相互作用,在酸性、中性水溶液中形成2∶1的主客体配合物,而在碱性溶液中则形成1∶1的主客体配合物。Gramine与Q[7]的主客体相互作用过程主要是以焓驱动为主的过程。相溶解度实验的结果表明当Q[7]的浓度为1.0×10~(-3)mol·L~(-1)时,可使Gramine的溶解度增大82倍。     

Voltammetric studies of the interaction of 6-mercaptopurine with cucurbit[7]uril and DNA

The interaction of 6-mercaptopurine (6-MP), an antitumor drug, with cucurbit[7]uril (Q[7]) and DNA in an acetate buffer solution was studied by differential pulse voltammetry (DPV) and cyclic voltammetry(CV). The electrochemical data indicated a 1:1 complex formation of 6-MP with Q[7] and DNA. The formation constants of these complexes were determined based on the variations in the current. Moreover, the interactions of the 6-MP-Q[7] inclusion complex with DNA have been investigated by means of voltammetry. The results suggested that 6-MP displayed a high affinity for Q[7] and that the inclusion complex did not decompose when it bound to DNA. It can be inferred from the experimental data that the binding model of 6-MP to DNA may be ??electrostatic binding??. In addition, the formation of inclusion complexes between Q[7] and 6-MP was confirmed by UV-Vis spectroscopy and the ¹H NMR technique.     

Solubility enhancement of kinetin through host–guest interactions with cucurbiturils

We explored the use of cucurbiturils to form inclusion complexes to overcome the solubility problems of kinetin, a plant cytokinin. Inclusion complexes between kinetin and Q[7], TMeQ[6] and HMeQ[6] in aqueous solution and in solid state were investigated by phase solubility studies, ¹H NMR and IR. The effects of pH and temperature on complex stability were also investigated. Phase solubility studies showed that kinetin solubility increased in a linear fashion as a function of Q[7] and TMeQ[6] concentrations. However, kinetin solubility increased first, then decreased as the HMeQ[6] concentration increased, and the maximum solubility of kinetin was achieved at 4.95 mM in HMeQ[6]. The solubility of kinetin as well as the stability constant of its complex with Q[7] were affected by the pH of the medium. The thermodynamic parameters of the complex formation were also determined, and it showed that the formation of the inclusion complexes between kinetin and Q[7] was enthalpy controlled, suggesting that hydrophobic and van der Waals interactions were the main driving forces. Moreover, we found that the size of the cavity of cucurbituril played an important role in the association process. The formation of inclusion complexes between Q[7], TMeQ[6] and HMeQ[6] with kinetin was confirmed by ¹H NMR, and IR spectroscopy showed the presence of inclusion complexes in solid state. Our results demonstrated that the complexation of kinetin with Q[n] could be used to improve the solubility of kinetin in aqueous solution.     

Cooperative binding of an anticancer drug in a guest–host–protein assembly

The supramolecular formation of an anticancer drug (6-mercaptopurine (6-MP)) in an acetate buffer solution was demonstrated through a host–guest interaction with the macrocyclic host cucurbit[7]uril (Q[7]) and bovine serum albumin (BSA). With the help of ultraviolet absorption and fluorescence spectroscopy, it was shown that a binary complex formed between 6-MP and Q[7] and/or BSA, and a specific binding interaction took place between 6-MP and Q[7] in the presence of BSA. The inclusion constants and thermodynamic parameters were determined at different temperatures. The data suggested that the formation of the binary 6-MP–Q[7] complex was driven by enthalpy in the presence of an unfavourable entropy, which was attributed to the van der Waals and hydrophobic interactions. The fluorescence quenching of BSA by 6-MP was a result of the formation of the 6-MP–BSA complex. This quenching occurred by a static quenching mechanism, and hydrophobic forces played predominant roles in the binding process. Moreover, the absorption data suggested that the interaction between 6-MP and Q[7] or BSA was a competitive process. In addition, the effect of 6-MP on BSA conformation was investigated by synchronous and 3D fluorescence spectra.     

Encapsulation of adefovir bis(l-leucine propyl)ester pro-virucide in cucurbit[7]uril and its activity against tobacco mosaic virus

The interaction of cucurbit[7]uril (Q[7]) with a pro-virucide, adefovir bis(l-leucine propyl)ester (PMEA-Leu) in aqueous solutions and in solid state was studied by ¹H NMR, UV absorption spectroscopy, fluorescence and IR spectroscopy. The ¹H NMR revealed that the leucine propyl moiety of the compound could be entrapped in the cavity of the host Q[7], and the other moiety except for leucine propyl moieties, including aminopurine, was probably located at the portal area of Q[7]. Absorption and fluorescence spectroscopy proved that the interaction of Q[7] with PMEA-Leu led to the formation of host–guest inclusion complexes (2:1) that were controlled by the concentration of the host Q[7]. Formation of the inclusion complex between Q[7] and PMEA-Leu was confirmed by IR spectroscopy in solid state. In addition, deliquescent stability studies indicated that the moisture stability of the host–guest complex was significantly enhanced. The phenomenon was explained by the fact that the formation of solid inclusion complexes can prevent the compounds from absorbing water. Finally, bioactivity of PMEA-Leu and its inclusion complex against tobacco mosaic virus (TMV) was tested. The compound PMEA-Leu and its inclusion complexes showed some inhibitory activity against TMV at 500 μg/ml in vivo.     

七元瓜环对阿糖胞苷稳定性的影响

研究了七元瓜环(Q[7])与抗癌药物阿糖胞苷(Ara-C)的不同质子化存在形式之间的超分子相互作用, 探讨了超分子包合作用对药物电离平衡常数及药物稳定性的影响. 结果表明, Q[7]使得Ara-C的pK_a降低了约0.3个单位, Q[7]与Ara-C的2种存在形式(Ara-C⁺及Ara-C)均可形成1∶1的主客体包结配合物, Ara-C以其嘧啶环进入Q[7]空腔, 而核糖环位于瓜环端口发生相互作用; Q[7]与Ara-C作用后对药物起到保护性载体的作用, 从而提高了药物的稳定性.     

Preparation and characterization of inclusion complexes of antitumor camptothecin with cucurbit[n = 7, 8]urils

The slightly water-soluble anticancer drug camptothecin (CPT) and its inclusion complexes with cucurbit[n = 7, 8]uril (Q[n] (n = 7, 8)) were investigated. The formation of 1:2 complexes with Q[n] (n = 7, 8) in aqueous solution was confirmed by fluorescence spectroscopy and the apparent stability constants were determined to be higher than 3.01 × 10¹² L²/mol². The solid inclusion complexes of CPT and Q[n] (n = 7, 8) were also prepared by the co-evaporation method and characterized by Fourier transformation-infrared spectroscopy, differential scanning calorimetry and powder X-ray diffraction. Aqueous solubility and dissolution studies indicate that the complexes exhibited significantly increased dissolution rates compared with the pure drug and physical mixtures. The potential of Q[7] or Q[8] for stabilizing lactone modality of CPT was investigated by the High Performance Liquid Chromatography (HPLC) method. The results reveal more than 63% CPT lactone form (active form) in CPT-Q[7] or Q[8] complexes compared to only 36% CPT lactone form in the absence of Q[7] or Q[8] after being incubated in the phosphate buffer solution (pH 7.4 at 37°C) for 5 h.     

Cucurbit[n]urils (n=7, 8) binding of camptothecin and the effects on solubility and reactivity of the anticancer drug

The interaction between cucurbit[n]uril (n = 7, 8)(Q[n]) with two forms namely lactone modality and carboxylate modality of anticancer drug camptothecin (CPT) was studied. The results revealed that the combination of Q[n] with the lactone form of CPT was observed by electronic absorption spectroscopy, fluorescence spectroscopy and ¹H NMR technique in the acid solution (pH 2) and the total stability constants β were also obtained by Job plot with a host:guest ratio of 2:1; while in the phosphate buffer solution (pH 7.4), only Q[8] bound the carboxylate form of CPT in ratio 1:1, but no obvious interaction between Q[7] and the carboxylate form of CPT was observed. The solubility of CPT was enhanced up to about 70 and 8 times at pH 2 due to the formation of interaction complexes with Q[7] and Q[8], respectively, by using phase solubility method. The cytotoxicity tests revealed that compared with the free CPT, the complexes of Q[n] and CPT had the same cytotoxic activity on the human lung cancer cell line A549 and murine macrophage cell line P388D1 and the moderate depressed activity on human leukaemia cell line K562.